Pfizer reaches $5.4B deal for Global Blood Therapeutics - 1breakingnews.com
- 2 years ago
The New York drugmaker is buying Global Blood Therapeutics, which sells a drug for sickle-cell disease and has two in development. It will pay $68.50 per share.
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews